Clinical Trial Update: DIATOR-Diabetes Intervention With Atorvastatin [Phase 1]

View source ↗

Summary

A Phase 1 trial investigating atorvastatin as a diabetes intervention (DIATOR) for Type 1 diabetes was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Lipitor (atorvastatin)

Snippet

Sponsor: Profil Institut für Stoffwechselforschung GmbH | Conditions: Type 1 Diabetes | Phase 1 | Status: TERMINATED